Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure
Abroad (travel likely)RecruitingPHASE3
Conditions
Acute Decompensated Heart Failure (ADHF)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Jena University Hospital, Jena, Thuringia, Germany
Kerckhoff-Klinik GmbH, Bad Nauheim, Germany
Herzzentrum Dresden GmbH Universitaetsklinik, Dresden, Germany
Universitaetsmedizin Goettingen, Göttingen, Germany
Contact: Study coordinator (Stephan von Haehling, Prof.) · stephan.von.haehling@med.uni-goettingen.de · +495513968196Universitaetsklinikum Leipzig AöR, Leipzig, Germany
Contact: Study coordinator (Rolf Wachter, Prof.) · rolf.wachter@medizin.uni-leipzig.de · +493419712825Herzzentrum Leipzig GmbH, Leipzig, Germany
Contact: Study coordinator (Holger Thiele, Prof.) · Holger.Thiele@helios-gesundheit.de · +49341865252500Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz, Germany
LMU Klinikum Muenchen AöR, München, Germany
Rostock University Medical Center, Rostock, Germany